0 211

Cited 0 times in

Clinical Study on Malignant Fibrous/Fibrohistiocytic Tumors

Other Title
악성 섬유성 및 섬유조직구성 종양에 대한 임상적 고찰-대한피부과학회 피부암 연구분과위원회 공동연구-
박, 병철; 김, 문범; 김, 일환; 신, 동훈; 윤, 숙정; 이, 미우; 이, 민걸; 이, 석정; 조, 광현; 허, 창훈; 황, 규광; 김, 유찬
Korean journal of dermatology, 47(2):180-185, 2009
Journal Title
Korean journal of dermatology; 대한피부과학회지
Background: Malignant fibrous/fibrohistiocytic tumors are uncommon soft tissue tumors which gives dermatologists special attention on differential diagnosis. However, there has not yet been a multicenter study on these tumors in Korea.

Objectives: The aim of this study was to investigate the epidemiology and clinical features of malignant fibrous/ fiborhistiocytic tumors.

Methods: A total of 62 patients from 11 training hospitals who had been confirmed with malignant fibrous/ fibrohistiocytic tumor were studied. A retrospective analysis of hospital records served as the data source for this study.

Results: Among patients with malignant fibrous/fibrohistiocytic tumors, the most common tumor type was dermatofibrosarcoma protuberance followed by malignant fibrohistiocytic. The male to female ratio among subjects was 1.38 to 1 and the mean age was 44 years old. Of the common complaints recorded, asymptomatic mass was the most frequent. The mean size of the subjects’ tumors was 2.9 cm in the long axis and 2.3 cm in the short axis with a mean tumor thickness of 2.1 mm. The most common site for tumors was the back followed by the thigh. The recurrence rate after primary treatment was 14.5% and metastasis developed in 5 of 62 patients.

Conclusion: This study is expected to be helpful for understanding the clinical and pathological characteristics of malignant fibrous/fibrohistiocytic tumors.
Clinical featureFibrousFibrohistiocytic tumorMalignant
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Dermatology
AJOU Authors
박, 병철
Full Text Link
RIS (EndNote)
XLS (Excel)


해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.